Skip to main content
Erschienen in: Annals of Surgical Oncology 10/2016

04.08.2016 | Breast Oncology

Utility of Clinical Breast Examinations in Detecting Local–Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer

verfasst von: Heather B. Neuman, MD, MS, Jessica R. Schumacher, PhD, Amanda B. Francescatti, MS, Taiwo Adesoye, MD, Stephen B. Edge, MD, FACS, Elizabeth S. Burnside, MD, MPH, MS, David J. Vanness, PhD, Menggang Yu, PhD, Yajuan Si, PhD, Dan McKellar, MD, David P. Winchester, MD, FACS, Caprice C. Greenberg, MD, MPH

Erschienen in: Annals of Surgical Oncology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Although breast cancer follow-up guidelines emphasize the importance of clinical examinations, prior studies suggest a small fraction of local–regional events occurring after breast conservation are detected by examination alone. Our objective was to examine how local–regional events are detected in a contemporary, national cohort of high-risk breast cancer survivors.

Methods

A stage-stratified sample of stage II/III breast cancer patients diagnosed in 2006–2007 (n = 11,099) were identified from 1217 facilities within the National Cancer Data Base. Additional data on local–regional and distant breast events, method of event detection, imaging received, and mortality were collected. We further limited the cohort to patients with breast conservation (n = 4854). Summary statistics describe local–regional event rates and detection method.

Results

Local–regional events were detected in 5.5 % (n = 265) of patients. Eighty-three percent were ipsilateral or contralateral in-breast events, and 17 % occurred within ipsilateral lymph nodes. Forty-eight percent of local–regional events were detected on asymptomatic breast imaging, 29 % by patients, and 10 % on clinical examination. Overall, 0.5 % of the 4854 patients had a local–regional event detected on examination. Examinations detected a higher proportion of lymph node events (8/45) compared with in-breast events (18/220). No factors were associated with method of event detection.

Discussion

Clinical examinations, as an adjunct to screening mammography, have a modest effect on local–regional event detection. This contradicts current belief that examinations are a critical adjunct to mammographic screening. These findings can help to streamline follow-up care, potentially improving follow-up efficiency and quality.
Literatur
1.
Zurück zum Zitat DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.CrossRefPubMed DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.CrossRefPubMed
2.
Zurück zum Zitat Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961–5.CrossRefPubMed Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961–5.CrossRefPubMed
4.
Zurück zum Zitat Neuman HB, Steffens NM, Jacobson N, et al. Oncologists’ perspectives of their roles and responsibilities during multi-disciplinary breast cancer follow-up. Ann Surg Oncol. 2016;23(3):708–14.CrossRefPubMed Neuman HB, Steffens NM, Jacobson N, et al. Oncologists’ perspectives of their roles and responsibilities during multi-disciplinary breast cancer follow-up. Ann Surg Oncol. 2016;23(3):708–14.CrossRefPubMed
5.
Zurück zum Zitat Neuman HB, Steffens N, Tevaarwerk AJ, Jacobson N, Smith MA, Greenberg CC. Oncologists’ priorities for breast cancer follow-up. J Clin Oncol. 2014;32(Suppl):abstr e20602. Neuman HB, Steffens N, Tevaarwerk AJ, Jacobson N, Smith MA, Greenberg CC. Oncologists’ priorities for breast cancer follow-up. J Clin Oncol. 2014;32(Suppl):abstr e20602.
6.
Zurück zum Zitat Neuman HB, Weiss JM, Schrag D, et al. Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol. 2013;20(13):4128–36.CrossRefPubMed Neuman HB, Weiss JM, Schrag D, et al. Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol. 2013;20(13):4128–36.CrossRefPubMed
7.
Zurück zum Zitat Neuman HB, Schumacher JR, Schneider DF, et al. Determinants of the type of oncologists providing breast cancer follow-up. In: Society of Surgical Oncology 68th annual symposium, Houston, TX, 25–28 March 2015. Neuman HB, Schumacher JR, Schneider DF, et al. Determinants of the type of oncologists providing breast cancer follow-up. In: Society of Surgical Oncology 68th annual symposium, Houston, TX, 25–28 March 2015.
8.
Zurück zum Zitat Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117–28.CrossRefPubMedPubMedCentral Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117–28.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Schnipper LE, Davidson NE, Wollins DS, et al. American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol. 2015;33(23):2563–77.CrossRefPubMed Schnipper LE, Davidson NE, Wollins DS, et al. American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol. 2015;33(23):2563–77.CrossRefPubMed
10.
Zurück zum Zitat van der Sangen MJ, Scheepers SW, Poortmans PM, Luiten EJ, Nieuwenhuijzen GA, Voogd AC. Detection of local recurrence following breast-conserving treatment in young women with early breast cancer: optimization of long-term follow-up strategies. Breast. 2013;22(3):351–6.CrossRefPubMed van der Sangen MJ, Scheepers SW, Poortmans PM, Luiten EJ, Nieuwenhuijzen GA, Voogd AC. Detection of local recurrence following breast-conserving treatment in young women with early breast cancer: optimization of long-term follow-up strategies. Breast. 2013;22(3):351–6.CrossRefPubMed
11.
Zurück zum Zitat Kontos M, Roy P, Rizos D, Hamed H. An evidence based strategy for follow up after breast conserving treatment for breast cancer. J Surg Oncol. 2011;104(3):223–7.CrossRefPubMed Kontos M, Roy P, Rizos D, Hamed H. An evidence based strategy for follow up after breast conserving treatment for breast cancer. J Surg Oncol. 2011;104(3):223–7.CrossRefPubMed
12.
Zurück zum Zitat Montgomery DA, Krupa K, Cooke TG. Locoregional relapse after breast cancer: most relapses occur late and are not clinically detected. Breast J. 2009;15(2):163–7.CrossRefPubMed Montgomery DA, Krupa K, Cooke TG. Locoregional relapse after breast cancer: most relapses occur late and are not clinically detected. Breast J. 2009;15(2):163–7.CrossRefPubMed
13.
Zurück zum Zitat Yau TK, Sze H, Soong IS, et al. Surveillance mammography after breast conservation therapy in Hong Kong: effectiveness and feasibility of risk-adapted approach. Breast. 2008;17(2):132–7.CrossRefPubMed Yau TK, Sze H, Soong IS, et al. Surveillance mammography after breast conservation therapy in Hong Kong: effectiveness and feasibility of risk-adapted approach. Breast. 2008;17(2):132–7.CrossRefPubMed
14.
Zurück zum Zitat Montgomery DA, Krupa K, Jack WJ, et al. Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer. 2007;96(12):1802–7.CrossRefPubMedPubMedCentral Montgomery DA, Krupa K, Jack WJ, et al. Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer. 2007;96(12):1802–7.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Houssami N, Abraham LA, Miglioretti DL, et al. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA. 2011;305(8):790–9.CrossRefPubMedPubMedCentral Houssami N, Abraham LA, Miglioretti DL, et al. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA. 2011;305(8):790–9.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Kerlikowske K, Hubbard RA, Miglioretti DL, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155(8):493–502.CrossRefPubMedPubMedCentral Kerlikowske K, Hubbard RA, Miglioretti DL, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011;155(8):493–502.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353(17):1773–83.CrossRefPubMed Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353(17):1773–83.CrossRefPubMed
19.
Zurück zum Zitat Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009;50(1):3–14.CrossRefPubMed Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009;50(1):3–14.CrossRefPubMed
20.
Zurück zum Zitat Sharpe RE Jr, Venkataraman S, Phillips J, et al. Increased cancer detection rate and variations in the recall rate resulting from implementation of 3D digital breast tomosynthesis into a population-based screening program. Radiology. 2016;278(3):698–706.CrossRefPubMed Sharpe RE Jr, Venkataraman S, Phillips J, et al. Increased cancer detection rate and variations in the recall rate resulting from implementation of 3D digital breast tomosynthesis into a population-based screening program. Radiology. 2016;278(3):698–706.CrossRefPubMed
21.
Zurück zum Zitat McDonald ES, Oustimov A, Weinstein SP, Synnestvedt MB, Schnall M, Conant EF. Effectiveness of digital breast tomosynthesis compared with digital mammography: outcomes analysis from 3 years of breast cancer screening. JAMA Oncol. 2016;2(6):737–43.CrossRefPubMed McDonald ES, Oustimov A, Weinstein SP, Synnestvedt MB, Schnall M, Conant EF. Effectiveness of digital breast tomosynthesis compared with digital mammography: outcomes analysis from 3 years of breast cancer screening. JAMA Oncol. 2016;2(6):737–43.CrossRefPubMed
22.
Zurück zum Zitat Conant EF, Beaber EF, Sprague BL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR Consortium. Breast Cancer Res Treat. 2016;156(1):109–16.CrossRefPubMed Conant EF, Beaber EF, Sprague BL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR Consortium. Breast Cancer Res Treat. 2016;156(1):109–16.CrossRefPubMed
23.
Zurück zum Zitat Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14(8):721–32.CrossRefPubMed Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14(8):721–32.CrossRefPubMed
24.
Zurück zum Zitat Cossetti RJ, Tyldesley SK, Speers CH, Zheng Y, Gelmon KA. Comparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008. J Clin Oncol. 2015;33(1):65–73.CrossRefPubMed Cossetti RJ, Tyldesley SK, Speers CH, Zheng Y, Gelmon KA. Comparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008. J Clin Oncol. 2015;33(1):65–73.CrossRefPubMed
25.
Zurück zum Zitat Colleoni M, Sun Z, Price KN, et al. Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V. J Clin Oncol. 2016;34(9):927–35.CrossRefPubMed Colleoni M, Sun Z, Price KN, et al. Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V. J Clin Oncol. 2016;34(9):927–35.CrossRefPubMed
26.
Zurück zum Zitat Liederbach E, Sisco M, Wang C, et al. Wait times for breast surgical operations, 2003–2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015;22(3):899–907.CrossRefPubMed Liederbach E, Sisco M, Wang C, et al. Wait times for breast surgical operations, 2003–2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015;22(3):899–907.CrossRefPubMed
27.
Zurück zum Zitat Neuman HB, Rathouz PJ, Winslow E, et al. Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providers. J Eval Clin Pract. doi:10.1111/jep.12529. Neuman HB, Rathouz PJ, Winslow E, et al. Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providers. J Eval Clin Pract. doi:10.​1111/​jep.​12529.
28.
Zurück zum Zitat Friese CR, Martinez KA, Abrahamse P, et al. Providers of follow-up care in a population-based sample of breast cancer survivors. Breast Cancer Res Treat. 2014;144(1):179–84.CrossRefPubMedPubMedCentral Friese CR, Martinez KA, Abrahamse P, et al. Providers of follow-up care in a population-based sample of breast cancer survivors. Breast Cancer Res Treat. 2014;144(1):179–84.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611–35.CrossRefPubMed Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611–35.CrossRefPubMed
30.
Zurück zum Zitat Anderson WF, Katki HA, Rosenberg PS. Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst. 2011;103(18):1397–1402.CrossRefPubMedPubMedCentral Anderson WF, Katki HA, Rosenberg PS. Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst. 2011;103(18):1397–1402.CrossRefPubMedPubMedCentral
Metadaten
Titel
Utility of Clinical Breast Examinations in Detecting Local–Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer
verfasst von
Heather B. Neuman, MD, MS
Jessica R. Schumacher, PhD
Amanda B. Francescatti, MS
Taiwo Adesoye, MD
Stephen B. Edge, MD, FACS
Elizabeth S. Burnside, MD, MPH, MS
David J. Vanness, PhD
Menggang Yu, PhD
Yajuan Si, PhD
Dan McKellar, MD
David P. Winchester, MD, FACS
Caprice C. Greenberg, MD, MPH
Publikationsdatum
04.08.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 10/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5483-x

Weitere Artikel der Ausgabe 10/2016

Annals of Surgical Oncology 10/2016 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.